The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
American Funds International Vntg 529-F3 CIVHX
- NAV / 1-Day Return 16.74 / +0.18 %
- Total Assets 2.0 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.600%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 250
- Status Open
- TTM Yield —
- Turnover 15%
USD | NAV as of Apr 29, 2024 | 1-Day Return as of Apr 29, 2024, 10:11 PM GMT+0
Morningstar’s Analysis CIVHX
Will CIVHX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 25.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Capital Group Central Cash Fund | 6.24 | 126.1 Mil | Cash and Equivalents |
Novo Nordisk A/S Class B | 3.69 | 74.6 Mil | Healthcare |
Fujitsu Ltd | 3.69 | 74.6 Mil | Technology |
ASML Holding NV | 2.79 | 56.5 Mil | Technology |
Safran SA | 2.69 | 54.4 Mil | Industrials |
SAP SE | 2.67 | 53.9 Mil | Technology |
TotalEnergies SE | 2.34 | 47.4 Mil | Energy |
AstraZeneca PLC | 2.01 | 40.6 Mil | Healthcare |
London Stock Exchange Group PLC | 1.93 | 39.1 Mil | Financial Services |
Taiwan Semiconductor Manufacturing Co Ltd ADR | 1.79 | 36.2 Mil | Technology |